1. CD44 in Ovarian Cancer Progression and Therapy Resistance—A Critical Role for STAT3
   Antons Martincuks et al, 2020, Frontiers in Oncology CrossRef
2. Bruceine D Sensitizes Human Ovarian Cancer Cells to Paclitaxel Through JNK and STAT3 Signal Regulation
   Zhipeng Yan et al, 2022, Revista Brasileira de Farmacognosia CrossRef
3. Bruceine D inhibits Cell Proliferation Through Downregulating LINC01667/MicroRNA-138-5p/Cyclin E1 Axis in Gastric Cancer
   Lin Li et al, 2020, Frontiers in Pharmacology CrossRef
4. Insight into the Dual Inhibition Mechanism of Corilagin against MRSA Serine/Threonine Phosphatase (Stp1) by Molecular Modeling
   Yanan Yang et al, 2020, ACS Omega CrossRef
5. Synergistic Herb Interactions with Anticancer Drugs
   Shanmugam Hemaiswarya et al, 2022, Herb-Drug Combinations CrossRef
6. Research progress on the mechanism of glycolysis in ovarian cancer
   Chan Li et al, 2023, Frontiers in Immunology CrossRef
7. Integrated Chinese Herbal Medicine Therapy Improves the Survival of Patients With Ovarian Cancer
   Cherry Yin-Yi Chang et al, 2019, Integrative Cancer Therapies CrossRef
8. Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8
   Fanghua Qiu et al, 2019, Anti-Cancer Agents in Medicinal Chemistry CrossRef
9. Corilagin from longan seed: Identification, quantification, and synergistic cytotoxicity on SKOv3ip and hey cells with ginsenoside Rh2 and 5-fluorouracil
   Ni Li et al, 2018, Food and Chemical Toxicology CrossRef
10. Repositioning anticancer drugs as novel COVID-19 antivirals: targeting structural and functional similarities between viral proteins and cancer
    Zheng Yao Low et al, 2022, Expert Reviews in Molecular Medicine CrossRef
11. The latest research progress: Active components of Traditional Chinese medicine as promising candidates for ovarian cancer therapy
    Xiaoyu Zhang et al, 2025, Journal of Ethnopharmacology CrossRef
12. Corilagin exhibits differential anticancer effects through the modulation of STAT3/5 and MAPKs in human gastric cancer cells
    Min Hee Yang et al, 2022, Phytotherapy Research CrossRef
13. Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy
    Shan Wang et al, 2021, Pharmacological Research CrossRef
14. Corilagin suppresses RANKL‐induced osteoclastogenesis and inhibits oestrogen deficiency‐induced bone loss via the NF‐κB and PI3K/AKT signalling pathways
    Jinwei Lu et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
15. Geranium wilfordii maxim.: A review of its traditional uses, phytochemistry, pharmacology, quality control and toxicology
    Chao He et al, 2022, Journal of Ethnopharmacology CrossRef
16. Targeting transforming growth factor‐ß signalling for cancer prevention and intervention: Recent advances in developing small molecules of natural origin
    Devesh Tewari et al, 2022, Clinical and Translational Medicine CrossRef
17. Therapeutic targeting of SNAIL, RKIP, and YY1 in tumor metastasis and drug resistance
    Nadire Özenver et al, 2020, Prognostic and Therapeutic Applications of RKIP in Cancer CrossRef
18. Application of omics technologies in studies on antitumor effects of Traditional Chinese Medicine
    Peng Tan et al, 2024, Chinese Medicine CrossRef
19. Non-flavonoids Targeting Cancer Stem Cells: A Promising Therapeutic Avenue for Cancer Treatment
    Faizan Uddin et al, 2021, Polyphenols-based Nanotherapeutics for Cancer Management CrossRef